Debug Stats | ### Total Build Time: 18 ms 37.833 KB CONCEPT_NAME gt=1 ms Completed: 1 ms rowSize= 346 bytesCONCEPT_SOLR_HIT_STATS gt=0 Completed: 0 ms rowSize= 14 bytes- Skipping details on:
CONCEPT_DEFINITION gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_SYNONYM gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_TEXT gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_SEMANTIC_TYPE gt=1 ms Completed: 1 ms rowSize= 14 bytes- Skipping details on:
CONCEPT_NAMESPACE gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_PARENTS gt=0 Completed: 0 ms rowSize= 7 bytesCONCEPT_CHILDREN gt=0 Completed: 0 ms rowSize= 8 bytesCONCEPT_ANCESTRAL_ROOTS gt=0 Completed: 0 ms rowSize= 15 bytesCONCEPT_RELATIONSHIPS gt=2 ms Completed: 2 ms rowSize= 106 bytesCONCEPT_GENES gt=13 ms Completed: 13 ms rowSize= 36.163 KBCONCEPT_XREFS gt=1 ms Completed: 1 ms rowSize= 1.158 KBCONCEPT_ANCILLARY gt=0 Completed: 0 ms rowSize= 14 bytes- Reload Stats
|
Genes (43)
Species: human : 43 | |
Human | EFHC1 | 114327 | EF-hand domain (C-terminal) containing 1 | | Human | KISS1R | 84634 | KISS1 receptor | Recent identification of loss-of-function mutations in GPR54, a receptor for kisspeptin-1, has highlighted a new pathway for the timing of puberty and reproductive control Mutations in GPR54 cause autosomal recessive idiopathic hypogonadotropic hypogonadism in humans and mice, suggesting that this receptor is essential for normal gonadotropin-releasing hormone physiology and for puberty KiSS-1/GPR54 system has been proven as an essential gatekeeper of GnRH neurons, involved in their activation at puberty and their regulation by gonadal steroids | Human | BSCL2 | 26580 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | Lytic cystic lesions in appendicular bones (occurs after puberty) Insulin-resistant diabetes mellitus at puberty | Human | AGPAT2 | 10555 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Insulin-resistant diabetes mellitus at puberty Lytic cystic lesions in appendicular bones (occurs after puberty) | Human | FBLN5 | 10516 | fibulin 5 | Onset of skin manifestations from birth to puberty | Human | FGF23 | 8074 | fibroblast growth factor 23 | Two main groups defined by age at onset: childhood (1 to 3 years) and onset after puberty | Human | TRPS1 | 7227 | trichorhinophalangeal syndrome I | Accelerated bone age after puberty Delayed bone age before puberty | Human | SRD5A2 | 6716 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) | Often reared as females until puberty Masculinization at puberty No breast development or menstruation at puberty | Human | SH3BP2 | 6452 | SH3-domain binding protein 2 | Progresses through puberty, then stabilizes | Human | PPARG | 5468 | peroxisome proliferator-activated receptor gamma | Onset of clinical features around puberty Insulin-resistant diabetes mellitus (onset around puberty) Loss of adipose tissue occurs around puberty | Human | NPY | 4852 | neuropeptide Y | higher concentrations of neuropeptide Y in constitutional delay of puberty(CDP) girls may be responsible for CDP and reduced levels of insulin growth factor-I(IGF-I) | Human | NEB | 4703 | nebulin | Scoliosis (onset around puberty) | Human | LMNA | 4000 | lamin A/C | Insulin-resistant diabetes mellitus (onset around puberty) Onset of clinical features around puberty Loss of adipose tissue occurs around puberty | Human | LEPR | 3953 | leptin receptor | Effect pf genetic and environmental factors on levels in female twins in puberty | Human | LEP | 3952 | leptin | leptin in the circulation may increase more rapidly during development than indicated by total leptin levels, and that these changes may serve as one of the signals to the central nervous system that metabolic conditions are adequate to support puberty Biphasic leptin decline, which exceeded the level expected, was independent of puberty, baseline adiposity and changes in adiposity, body composition, rate of weight loss, physical activity scores and insulin concentrations leptin level was significantly lower in the CDGP (constitutional delay of growth and puberty)group | Human | KRT14 | 3861 | keratin 14 | Onset of hyperpigmentation early childhood (3 months-6 years) fades after puberty | Human | KRT5 | 3852 | keratin 5 | | Human | KISS1 | 3814 | KiSS-1 metastasis-suppressor | Kisspeptin function appears to be fundamental to the initiation of puberty | Human | IHH | 3549 | indian hedgehog | Cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty | Human | IGFALS | 3483 | insulin-like growth factor binding protein, acid labile subunit | IGFALS sequence variants are unlikely to be a common association with pubertal delay in children with constitutional delay of groth and puberty Inactivation of the IGFALS gene caused delayed onset of puberty in 17 year old boy | Human | IGF1 | 3479 | insulin-like growth factor 1 (somatomedin C) | IGF-I level was significantly lower in the CDGP (constitutional delay of growth and puberty)group first study to document an association between timing of puberty and adult insulin-like growth factor 1(IGF-I) levels higher concentrations of neuropeptide Y in constitutional delay of puberty(CDP) girls may be responsible for CDP and reduced levels of insulin growth factor-I(IGF-I) Poor glycemic control and differences in IGF-I levels and androgens accompany development of microalbuminuria at puberty; differences may account for sexual dimorphism in microalbuminuria risk during puberty and to disease progression | Human | HSD17B3 | 3293 | hydroxysteroid (17-beta) dehydrogenase 3 | Normal virilization at puberty | Human | HMBS | 3145 | hydroxymethylbilane synthase | Acute attacks rarely occur before puberty | Human | GRM1 | 2911 | glutamate receptor, metabotropic 1 | Expression of mGluR1 increases in human with hypothalamic hamartoma and in the female monkey hypothalamus at puberty | Human | GNRHR | 2798 | gonadotropin-releasing hormone receptor | A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as constitutional delay of growth and puberty with subsequent borderline oligospermia |
|